MedTrace Logo

Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent

NCT03151577 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-05-05

No results posted yet for this study

Summary

To evaluate the safety and efficacy of the XEN® Gel Stent in mild to moderate glaucoma patients undergoing glaucoma surgery.

Conditions

  • Glaucoma
  • Glaucoma, Open-Angle
  • Glaucoma, Angle-Closure
  • Glaucoma, Primary Open Angle

Interventions

PROCEDURE

XEN® Gel Stent implantation

Minimally invasive glaucoma surgery (MIGS) which consists of implanting a XEN® Gel Stent in the irido-corneal angle of the eye to drain the aqueous humour in the sub-conjunctival space to lower the IOP.

Sponsors & Collaborators

  • Swiss Vision Network

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-01
Primary Completion
2019-01-31
Completion
2023-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03151577 on ClinicalTrials.gov